Leukaemia trial tests Covid vaccine strategies to combat immune suppression
Patients with the most common form of leukaemia – Chronic Lymphocytic Leukaemia (CLL) – are being invited to take part in a trial that could help them build Covid-19 antibodies following vaccination…
Funding renewal allows experimental cancer therapy research to continue in Birmingham
New and innovative ways to detect and treat cancer being trialled at the University of Birmingham are to receive renewed funding from Cancer Research UK and the NIHR.
The Birmingham Experimental C…
New device provides early diagnosis for cardiac tamponade
A new diagnostic device, developed to monitor against post-surgery heart strangulation risk, has been introduced by a company formed by Birmingham cardiothoracic surgeon Hazem Fallouh.
Patients re…
New heart attack drug trialled in Birmingham
A new partnership between BHP clinical-academic institutions and Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug, for the first time.
The…
The BHP Starter Fellowship – a catch-up with Karl
Dr Karl Payne is currently an NIHR funded Academic Clinical Lecturer in Oral & Maxillofacial Surgery and a Surgical Trainee in the West Midlands. He undertook a Birmingham Health Partners Sta…
Researchers make mini ‘bone-marrow-in-a-dish’ to test cancer treatments
Scientists from BHP and Oxford University have made the first bone marrow ‘organoids’ that capture the key features of human bone marrow. The technology, for which University of Birmingham Enterprise…